Premium
Clinical evaluation of MK‐185: A new hypolipidemic drug
Author(s) -
Sirtori Cesare,
Hurwitz Aryeh,
Sabih Khalid,
Azarnoff Daniel L.
Publication year - 1972
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/bf02532594
Subject(s) - clinical chemistry , lipidology , drug , triglyceride , plasma levels , pharmacology , medicine , chemistry , cholesterol
A double‐blind crossover study in 11 patients suggests that MK‐185 may be a useful drug in lowering plasma triglyceride levels, whereas it has minimal effects on cholesterol levels. A good correlation between the hypouricemic and protein bound iodine lowering effects and plasma level of MK‐185 was seen. No correlation with the hypolipidemic effect was noted.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom